A citation-based method for searching scientific literature

Fatemeh Khatami, Bagher Larijani, Shekoufeh Nikfar, Mandana Hasanzad, Kiarad Fendereski, Seyed Mohammad Tavangar. Pharmgenomics Pers Med 2019
Times Cited: 6







List of co-cited articles
10 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Biologic and Clinical Perspectives on Thyroid Cancer.
James A Fagin, Samuel A Wells. N Engl J Med 2016
327
33

Integrated Genomic Analysis of Hürthle Cell Cancer Reveals Oncogenic Drivers, Recurrent Mitochondrial Mutations, and Unique Chromosomal Landscapes.
Ian Ganly, Vladimir Makarov, Shyamprasad Deraje, YiYu Dong, Ed Reznik, Venkatraman Seshan, Gouri Nanjangud, Stephanie Eng, Promita Bose, Fengshen Kuo,[...]. Cancer Cell 2018
89
33

RET/PTC Gene Rearrangements in Thyroid Carcinogenesis: Assessment and Clinico-Pathological Correlations.
Mosin S Khan, Qurteeba Qadri, Mudasir J Makhdoomi, Muneer A Wani, Aejaz A Malik, Madiha Niyaz, Shariq R Masoodi, Khurshid I Andrabi, Rauf Ahmad, Syed Mudassar. Pathol Oncol Res 2020
12
33

Molecular pathology of thyroid tumours of follicular cells: a review of genetic alterations and their clinicopathological relevance.
Giorgia Acquaviva, Michela Visani, Andrea Repaci, Kerry J Rhoden, Dario de Biase, Annalisa Pession, Tallini Giovanni. Histopathology 2018
54
33

Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.
Freddie Bray, Jacques Ferlay, Isabelle Soerjomataram, Rebecca L Siegel, Lindsey A Torre, Ahmedin Jemal. CA Cancer J Clin 2018
33

2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer.
Bryan R Haugen, Erik K Alexander, Keith C Bible, Gerard M Doherty, Susan J Mandel, Yuri E Nikiforov, Furio Pacini, Gregory W Randolph, Anna M Sawka, Martin Schlumberger,[...]. Thyroid 2016
33

Lenvatinib versus placebo in radioiodine-refractory thyroid cancer.
Martin Schlumberger, Makoto Tahara, Lori J Wirth, Bruce Robinson, Marcia S Brose, Rossella Elisei, Mouhammed Amir Habra, Kate Newbold, Manisha H Shah, Ana O Hoff,[...]. N Engl J Med 2015
839
33

Molecular genetics and diagnosis of thyroid cancer.
Yuri E Nikiforov, Marina N Nikiforova. Nat Rev Endocrinol 2011
576
33

Trends in Thyroid Cancer Incidence and Mortality in the United States, 1974-2013.
Hyeyeun Lim, Susan S Devesa, Julie A Sosa, David Check, Cari M Kitahara. JAMA 2017
753
33

Nomenclature Revision for Encapsulated Follicular Variant of Papillary Thyroid Carcinoma: A Paradigm Shift to Reduce Overtreatment of Indolent Tumors.
Yuri E Nikiforov, Raja R Seethala, Giovanni Tallini, Zubair W Baloch, Fulvio Basolo, Lester D R Thompson, Justine A Barletta, Bruce M Wenig, Abir Al Ghuzlan, Kennichi Kakudo,[...]. JAMA Oncol 2016
752
33



MicroRNA-based molecular classification of papillary thyroid carcinoma.
Francesca Rosignolo, Lorenzo Memeo, Fabio Monzani, Cristina Colarossi, Valeria Pecce, Antonella Verrienti, Cosimo Durante, Giorgio Grani, Livia Lamartina, Stefano Forte,[...]. Int J Oncol 2017
47
16

Molecular profiling of cancer patients enables personalized combination therapy: the I-PREDICT study.
Jason K Sicklick, Shumei Kato, Ryosuke Okamura, Maria Schwaederle, Michael E Hahn, Casey B Williams, Pradip De, Amy Krie, David E Piccioni, Vincent A Miller,[...]. Nat Med 2019
181
16

Anaplastic thyroid carcinoma: from clinicopathology to genetics and advanced therapies.
Eleonora Molinaro, Cristina Romei, Agnese Biagini, Elena Sabini, Laura Agate, Salvatore Mazzeo, Gabriele Materazzi, Stefano Sellari-Franceschini, Alessandro Ribechini, Liborio Torregrossa,[...]. Nat Rev Endocrinol 2017
167
16


Malignant risk stratification of thyroid FNA specimens with indeterminate cytology based on molecular testing.
Svetlana Paskaš, Jelena Janković, Vladan Živaljević, Svetislav Tatić, Vesna Božić, Aleksandra Nikolić, Dragica Radojković, Svetlana Savin, Dubravka Cvejić. Cancer Cytopathol 2015
20
16

Differences in miRNA and mRNA Profile of Papillary Thyroid Cancer Variants.
Tomasz Stokowy, Danuta Gawel, Bartosz Wojtas. Int J Endocrinol 2016
20
16

RAS mutations in thyroid FNA specimens are highly predictive of predominantly low-risk follicular-pattern cancers.
Nikhil Gupta, Anil K Dasyam, Sally E Carty, Marina N Nikiforova, N Paul Ohori, Michaele Armstrong, Linwah Yip, Shane O LeBeau, Kelly L McCoy, Christopher Coyne,[...]. J Clin Endocrinol Metab 2013
98
16

RAS mutations in thyroid cancer.
Gina M Howell, Steven P Hodak, Linwah Yip. Oncologist 2013
104
16

Expressions of miRNAs in papillary thyroid carcinoma and their associations with the clinical characteristics of PTC.
Jianxia Hu, Chengqian Li, Chongkai Liu, Shihua Zhao, Yangang Wang, Zhengju Fu. Cancer Biomark 2017
21
16

Changing the Cancer Diagnosis: The Case of Follicular Variant of Papillary Thyroid Cancer-Primum Non Nocere and NIFTP.
Steven Hodak, R Michael Tuttle, Guy Maytal, Yuri E Nikiforov, Gregory Randolph. Thyroid 2016
31
16

Performance of a Genomic Sequencing Classifier for the Preoperative Diagnosis of Cytologically Indeterminate Thyroid Nodules.
Kepal N Patel, Trevor E Angell, Joshua Babiarz, Neil M Barth, Thomas Blevins, Quan-Yang Duh, Ronald A Ghossein, R Mack Harrell, Jing Huang, Giulia C Kennedy,[...]. JAMA Surg 2018
120
16

Current thyroid cancer trends in the United States.
Louise Davies, H Gilbert Welch. JAMA Otolaryngol Head Neck Surg 2014
898
16

Preoperative detection of RAS mutation may guide extent of thyroidectomy.
Snehal G Patel, Sally E Carty, Kelly L McCoy, N Paul Ohori, Shane O LeBeau, Raja R Seethala, Marina N Nikiforova, Yuri E Nikiforov, Linwah Yip. Surgery 2017
37
16

Two-miRNA classifiers differentiate mutation-negative follicular thyroid carcinomas and follicular thyroid adenomas in fine needle aspirations with high specificity.
Tomasz Stokowy, Bartosz Wojtas, Barbara Jarzab, Knut Krohn, David Fredman, Henning Dralle, Thomas Musholt, Steffen Hauptmann, Dariusz Lange, László Hegedüs,[...]. Endocrine 2016
17
16

Genomic and transcriptomic hallmarks of poorly differentiated and anaplastic thyroid cancers.
Iñigo Landa, Tihana Ibrahimpasic, Laura Boucai, Rileen Sinha, Jeffrey A Knauf, Ronak H Shah, Snjezana Dogan, Julio C Ricarte-Filho, Gnana P Krishnamoorthy, Bin Xu,[...]. J Clin Invest 2016
478
16

Long non-coding RNA in cancer.
Nina Hauptman, Damjan Glavač. Int J Mol Sci 2013
246
16

Development and validation of a clinical cancer genomic profiling test based on massively parallel DNA sequencing.
Garrett M Frampton, Alex Fichtenholtz, Geoff A Otto, Kai Wang, Sean R Downing, Jie He, Michael Schnall-Levin, Jared White, Eric M Sanford, Peter An,[...]. Nat Biotechnol 2013
16

Highly prevalent TERT promoter mutations in aggressive thyroid cancers.
Xiaoli Liu, Justin Bishop, Yuan Shan, Sara Pai, Dingxie Liu, Avaniyapuram Kannan Murugan, Hui Sun, Adel K El-Naggar, Mingzhao Xing. Endocr Relat Cancer 2013
370
16

Genetic Analysis of 779 Advanced Differentiated and Anaplastic Thyroid Cancers.
Nikita Pozdeyev, Laurie M Gay, Ethan S Sokol, Ryan Hartmaier, Kelsi E Deaver, Stephanie Davis, Jena D French, Pierre Vanden Borre, Daniel V LaBarbera, Aik-Choon Tan,[...]. Clin Cancer Res 2018
164
16

MiR-19a Overexpression in FTC-133 Cell Line Induces a More De-Differentiated and Aggressive Phenotype.
Giovanna Calabrese, Anna Dolcimascolo, Filippo Torrisi, Agata Zappalà, Rosario Gulino, Rosalba Parenti. Int J Mol Sci 2018
10
16

A meta-analysis of prognostic roles of molecular markers in papillary thyroid carcinoma.
Huy Gia Vuong, Uyen N P Duong, Ahmed M A Altibi, Hanh T T Ngo, Thong Quang Pham, Hung Minh Tran, Greta Gandolfi, Lewis Hassell. Endocr Connect 2017
37
16

Translational applications of microRNAs in cancer, and therapeutic implications.
Grace T Kwok, Jing Ting Zhao, Jocelyn Weiss, Nancy Mugridge, Himanshu Brahmbhatt, Jennifer A MacDiarmid, Bruce G Robinson, Stan B Sidhu. Noncoding RNA Res 2017
25
16

Histone deacetylases and cancer: causes and therapies.
P Marks, R A Rifkind, V M Richon, R Breslow, T Miller, W K Kelly. Nat Rev Cancer 2001
16

Suppression of BRAF/MEK/MAP kinase pathway restores expression of iodide-metabolizing genes in thyroid cells expressing the V600E BRAF mutant.
Dingxie Liu, Shuiying Hu, Peng Hou, David Jiang, Stephen Condouris, Mingzhao Xing. Clin Cancer Res 2007
130
16

Thyroid cancer.
Maria E Cabanillas, David G McFadden, Cosimo Durante. Lancet 2016
463
16

Association between BRAF V600E mutation and mortality in patients with papillary thyroid cancer.
Mingzhao Xing, Ali S Alzahrani, Kathryn A Carson, David Viola, Rossella Elisei, Bela Bendlova, Linwah Yip, Caterina Mian, Federica Vianello, R Michael Tuttle,[...]. JAMA 2013
549
16

Vemurafenib in patients with BRAF(V600E)-positive metastatic or unresectable papillary thyroid cancer refractory to radioactive iodine: a non-randomised, multicentre, open-label, phase 2 trial.
Marcia S Brose, Maria E Cabanillas, Ezra E W Cohen, Lori J Wirth, Todd Riehl, Huibin Yue, Steven I Sherman, Eric J Sherman. Lancet Oncol 2016
146
16

Correlation between genetic alterations and microscopic features, clinical manifestations, and prognostic characteristics of thyroid papillary carcinomas.
Adebowale J Adeniran, Zhaowen Zhu, Manoj Gandhi, David L Steward, James P Fidler, Thomas J Giordano, Paul W Biddinger, Yuri E Nikiforov. Am J Surg Pathol 2006
338
16

Everolimus in Anaplastic Thyroid Cancer: A Case Series.
Ethan J Harris, Glenn J Hanna, Nicole Chau, Guilherme Rabinowits, Robert Haddad, Danielle N Margalit, Jonathan Schoenfeld, Roy B Tishler, Justine A Barletta, Matthew Nehs,[...]. Front Oncol 2019
12
16

Clinical outcomes and molecular profile of differentiated thyroid cancers with radioiodine-avid distant metastases.
M M Sabra, J M Dominguez, R K Grewal, S M Larson, R A Ghossein, R M Tuttle, J A Fagin. J Clin Endocrinol Metab 2013
64
16

MiR-137 acts as a tumor suppressor in papillary thyroid carcinoma by targeting CXCL12.
Su Dong, Meishan Jin, Ye Li, Peiyou Ren, Jia Liu. Oncol Rep 2016
34
16

Selective RET kinase inhibition for patients with RET-altered cancers.
V Subbiah, V Velcheti, B B Tuch, K Ebata, N L Busaidy, M E Cabanillas, L J Wirth, S Stock, S Smith, V Lauriault,[...]. Ann Oncol 2018
159
16

DNA methylation in thyroid cancer.
Carles Zafon, Joan Gil, Beatriz Pérez-González, Mireia Jordà. Endocr Relat Cancer 2019
13
16

Gene Expression Classifier Testing and the Surgical Decision-Making Process for Patients With Thyroid Nodules-Reply.
Salem I Noureldine, Martha A Zeiger, Ralph P Tufano. JAMA Otolaryngol Head Neck Surg 2016
1
100


Mutational profile of advanced primary and metastatic radioactive iodine-refractory thyroid cancers reveals distinct pathogenetic roles for BRAF, PIK3CA, and AKT1.
Julio C Ricarte-Filho, Mabel Ryder, Dhananjay A Chitale, Michael Rivera, Adriana Heguy, Marc Ladanyi, Manickam Janakiraman, David Solit, Jeffrey A Knauf, R Michael Tuttle,[...]. Cancer Res 2009
357
16

BRAF mutation detection in indeterminate thyroid cytology specimens: underlying cytologic, molecular, and pathologic characteristics of papillary thyroid carcinoma.
N Paul Ohori, Rashi Singhal, Marina N Nikiforova, Linwah Yip, Karen E Schoedel, Christopher Coyne, Kelly L McCoy, Shane O LeBeau, Steven P Hodak, Sally E Carty,[...]. Cancer Cytopathol 2013
56
16

The role of microRNAs in the pathogenesis of thyroid cancer.
Soudeh Ghafouri-Fard, Zeinab Shirvani-Farsani, Mohammad Taheri. Noncoding RNA Res 2020
12
16


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.